Nasopharyngeal carriage of Streptococcus pneumoniae in healthy children, 2 to 24 months of age, in New-Caledonia;Étude du portage rhinopharyngé de Streptococcus pneumoniae chez les enfants sains âgés de 2 à 24 mois en Nouvelle-Calédonie

Medecine et Maladies Infectieuses

Volumn 35, Issue 10, 2005, Pages 500-506

  Charveriat M A ^a   Chomarat, M ^b   Watson, M ^c   Garin, B ^a  

^a Institut Pasteur de Nouvelle Caledonie Noumea   (New Caledonia)

^b CENTRE HOSPITALIER LYON SUD   (France)

^c CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

Anti pneumococcal vaccine; Nasopharyngeal carriage; Streptococcus pneumoniae

Indexed keywords

PENICILLIN G; ANTIINFECTIVE AGENT;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL STRAIN; ETHNOLOGY; HUMAN; IMMUNIZATION; INFANT; NEW CALEDONIA; PRESCHOOL CHILD; PREVALENCE; RHINOPHARYNGITIS; RISK FACTOR; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; TIME SERIES ANALYSIS; VACCINATION; DISEASE TRANSMISSION; DRUG EFFECT; IMMUNOLOGY; ISOLATION AND PURIFICATION; MICROBIOLOGY; NASOPHARYNX; REFERENCE VALUE; STREPTOCOCCUS INFECTION;

ANTI-BACTERIAL AGENTS; CHILD, PRESCHOOL; HUMANS; INFANT; NASOPHARYNX; NEW CALEDONIA; PNEUMOCOCCAL INFECTIONS; REFERENCE VALUES; RISK FACTORS; STREPTOCOCCUS PNEUMONIAE;

EID: 28844452962     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2005.08.009     Document Type: Article

References (13)

1. Avis du conseil supérieur d'hygiène publique de France section des maladies transmissibles relatif à la vaccination par le vaccin pneumococcique heptavalent conjugué (Prevenar®) (Séance du 8 mars, bulletin officiel N°2002-13).
2. W. Roos Recensement de la population en Nouvelle-Caĺdonie, INSEE.No506-Janvier 1997
3. Aujard Y, Lavy C, De la Rocque F, Bingen E, Varon E, Alonso JM, et al. Pediatric bacterial meningitis in France: a two year multicenter prospective survey. 43rd Annual ICAAC abstracts, 14-17 sept. 2003, Chicago, Illinois, USA : G1559. http://193.251.4.4:9000/index.html.
4. Michel N. Streptococcus pneumoniae en Nouvelle-Calédonie : sérotypes, résistance aux bêta-lactamines, étude de la couverture vaccinale. Thèse de Pharmacie, Lyon, 2002.
5. M.J. Perilla, J. Elliot, and R. Facklam Manual for the laboratory identification and antimicrobial resistance testing of bacterial pathogens of public health importance in developing World Health Organization, Geneva 2003 Centers for Disease Control Atlanta
6. J. Raymond, R. Cohen, F. Moulin, D. Gendrel, and P. Berche Facteurs influeņant le portage de Streptococcus pneumoniae Med. Mal. Infect. 32 Suppl 1 2002 13 20
7. R.Y. Sung, J.M. Ling, S.M. Fung, S.J. Oppenheimer, D.W. Crook, and J.T. Lau Carriage of Haemophilus influenzae and Streptococcus pneumoniae in healthy Chinese and Vietnamese children in Hong Kong Acta Paediatr. 84 11 1995 1262 1267
8. X. Yu, B. Grays, S. Chang, J. Ward, K. Edwards, and M. Nahm Immunity to cross-reactive serotypes induced by pneumococcal conjugate vaccines in infants J. Infect. Dis. 180 1999 1569 1576
9. R. Dagan, R. Melamed, M. Muallem, L. Piglansky, D. Greenberg, and O. Abramson Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine J. Infect. Dis. 174 6 1996 1271 1278
10. K.P. Klugman Efficacy of pneumococcal conjugate vaccines and their effect on carriage and antimicrobial resistance Lancet 1 2001 85 91
11. J. Eskola, T. Kilpi, A. Palmu, J. Jokinen, J. Haapakoski, and E. Herva Efficacy of a pneumococcal conjugate vaccine against acute otitis media N. Engl. J. Med. 344 6 2001 403 409
12. S. Black, H. Shinefield, R. Baxter, R. Austrian, L. Bracken, and J. Hansen Postlicensure surveillance for pneumococcal invasive vaccine in Northern California Kaiser Permanente Pediatr. Infect. Dis. J. 23 2004 485 489
13. C.G. Whitney, M.M. Farley, J. Hadler, L.H. Harrison, N.M. Bennett, and R. Lynfield Decline in invasive pneumococcal diease after the introduction of protein-polysaccharide conjugate vaccine N. Engl. J. Med. 348 18 2003 1737 1746